Article Data

  • Views 465
  • Dowloads 101

Case Reports

Open Access

Steroid cell tumor of the ovary associated with endometrial adenocarcinoma – a rare case report

  • A. Aydin1
  • S. Ozkanli1,*,
  • E. Zemheri1
  • B. Girgin1
  • K. Guzin2
  • A. Gocmen2

1Department of Pathology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey

2Department of Obstetrics and Gynecology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey

DOI: 10.12892/ejgo2597.2015 Vol.36,Issue 3,June 2015 pp.348-350

Published: 10 June 2015

*Corresponding Author(s): S. Ozkanli E-mail: seymaozkanli@gmail.com

Abstract

Endometrial carcinoma is the most common invasive neoplasm of the female genital tract and is associated to the elevated levels of unopposed estrogen, especially in postmenopause. Ovarian Steroid cell tumors are rare tumors and they are named according to the origin of cell. The most common cancer of the female genital tract is the endometrial adenocarcinoma and it accounts for 7% of all invasive cancers in women. In the present case report, the authors present a 59-year-old multiparous woman with a postmenopausal bleeding complaint and they discuss the case of ovarian steroid cell tumor associated with endometrioid adenocarcinoma of endometrium. Endometrial adenocarcinoma is the most common cancer of female genital tract and its contemporarity with an ovarian steroid cell tumor is extremely rare.

Keywords

Steroid cell tumor; Ovary; Endometrium; Adenocarcinoma.

Cite and Share

A. Aydin,S. Ozkanli,E. Zemheri,B. Girgin,K. Guzin,A. Gocmen. Steroid cell tumor of the ovary associated with endometrial adenocarcinoma – a rare case report. European Journal of Gynaecological Oncology. 2015. 36(3);348-350.

References

[1] Longacre T.A., Atkins K.A., Kempson R.L., Hendrickson M.R., Clement P. B., Young R.H. (eds.): “Sternberg’s diagnostic surgical pathology”, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2009, 2207.

[2] Zaloudek C.J., Garg K., Mutter G.L.: “Tumors of the female genital tract”. In: Fletcher C.D.M. (ed). Diagnostic histopathology of tumors. 4th ed. Philadelphia: Elsevier Saunders, 2013, 703.

[3] Ghazala M., Hena A. A., Rana K. S., Khaliqur R., Nishat A.: “Overian steroid cell tumor: correlation of histopathology with clinicopathologic features”. Patholog Res. Int., 2011, 2011, 987895. doi: 10.4061/2011/987895.

[4] Ellenson H.L., Ronnett B.M., Soslow R.A., Zaino R.J., Kurman R. J., Young R.H. (eds.): “Endometrial carcinoma”, In: Blaustein’s pathology of the female genital tract, 6th ed. New York: Springer Verlag. 2011, 394

[5] Huang T., Holaday W.J.: “An ovarian hilus-cell tumor associated with endometrial carcinoma: report of a case”. Am. J. Clin. Pathol., 1970, 54, 147.

[6] Luk W.T., Lee N., Chang T.C., Chu K.K.: “Lipid cell tumor of the ovary associated with endometrial adenocarcinoma—a case report”. Changgeng Yi Xue Za Zhi, 1989, 12, 244.

[7] Ichinohasama R., Teshima S., Kishi K., Mukai K., Tsunematsu R., Ishii-Ohba H., Shimosato Y.: “Leydig cell tumor of the ovary associated with endometrial carcinoma and containing 17 beta-hydroxysteroid dehydrogenase”. Int. J. Gynecol. Pathol., 1989, 8, 64.

[8] Roth L.M., Czernobilsky B.: “Perspectives on pure ovarian stromal neoplasms and tumor-like proliferations of the ovarian stroma”. Am. J. Surg. Pathol., 2011, 35, e15.

[9] Wei J., Xiang T., Fang F., Shaofen Z., Conjion X.: “Benign and malignant ovarian steroid cell tumors, not otherwise specified case studies, comparison, and review of the literature”. J. Ovarian Res., 2013, 6, 53.

[10] Outwater E.K.,Wagner B.J., Mannion C., Mc Larney J.K., Kim B.: “Sex cord stromal and steroid cell tumors of the ovary”. Radiographics, 1998, 6, 1523.

[11] Hayes M.C., Scully R.E.: “Ovarian steroid cell tumors (not otherwise specified): a clinicopathological analysis of 63 cases”. Am. J. Surg. Pathol., 1987, 11, 835.

[12] Rosai J.: “Rosai and Ackerman’s surgical pathology”, 10th ed. Edinburgh: Mosby, 2011, 2, 1492.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top